LifeRaft Biosciences
LifeRaft Biosciences
Categories
Biotechnology Biotech Pharmaceutical
About
LifeRaft Biosciences is a Philadelphia-based biotechnology company focused on developing innovative therapies that repair damaged cell membranes and reduce tissue injury. Its lead drug candidate, Vepoloxamer, is being developed to prevent severe oral mucositis caused by radiation therapy in head and neck cancer patients. The company is also exploring treatments for acute burns and other injuries involving cellular damage, aiming to improve patient outcomes through advanced membrane-repair technology.
Industry News & Announcements
Get Updates
from LSPA
Stay up-to-date on the latest news and events from Life Sciences PA, insights from the life sciences industry, and so much more!
Life Sciences Pennsylvania was founded in 1989 by a biotech scientist at Penn State University. Today it has grown to represent the entire life sciences industry – biotechnology and diagnostic companies, medical device companies, pharmaceutical companies, investment organizations, research institutions, and myriad service industries that support the life sciences in Pennsylvania.